VANCOUVER, BC / ACCESSWIRE / November 21, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces the full integration of the “Carotid
VANCOUVER, BC / ACCESSWIRE / November 15, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces partnership with Rogan Molding Technologies. The
VANCOUVER, BC / ACCESSWIRE / September 28, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces the addition of Mr. Tim Knisley
VANCOUVER, BC / ACCESSWIRE / September 20, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) enters discussions with Key Opinion Leaders in
VANCOUVER, BC / ACCESSWIRE / September 14, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces the addition of Mr. Alan Langston
VANCOUVER, BC / ACCESSWIRE / September 11, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce that an institutional
VANCOUVER, BC / ACCESSWIRE / September 8, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces that Jeremy Poirier has provided his
VANCOUVER, BC / ACCESSWIRE / September 7, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) advisory staff member Dr. Phillip J. Bendick,
VANCOUVER, BC / ACCESSWIRE / August 22, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce the addition of
VANCOUVER, BC / ACCESSWIRE / August 8th, 2017 / CVR Global Inc., on behalf of CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) has
VANCOUVER, BC / ACCESSWIRE / June 29, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce that Thomas Jefferson
VANCOUVER, BC / ACCESSWIRE / June 2, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce that CVR Medical
CVR Medical Corp. is a med-tech organization dedicated to the development and advancement of revolutionary technology at work within the healthcare sector. Specifically, The Carotid Stenotic Scan (CSS), a groundbreaking tool which will be used to assess Carotid Arterial health in a way which is unavailable to the patient, healthcare provider, and the payor within the current system. By leveraging intellectual property, market and industry know-how, and key strategic relationships, CVR Medical has entered into a trajectory which will revolutionize healthcare and dramatically improve clinical outcomes.